CVE-2020-15050

CVE-2020-15050 is a high-severity vulnerability in Supremainc Biostar 2 with a CVSS 3.x base score of 7.5. Its EPSS exploit-prediction score of 51% places it in the 99th percentile, indicating an elevated likelihood of exploitation. The underlying weakness is classified as CWE-22.

Key facts

Description

An issue was discovered in the Video Extension in Suprema BioStar 2 before 2.8.2. Remote attackers can read arbitrary files from the server via Directory Traversal.

Frequently asked questions

What is CVE-2020-15050?
An issue was discovered in the Video Extension in Suprema BioStar 2 before 2.8.2. Remote attackers can read arbitrary files from the server via Directory Traversal.
How severe is CVE-2020-15050?
CVE-2020-15050 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2020-15050 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 51% (99th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-15050?
CVE-2020-15050 affects Supremainc Biostar 2. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2020-15050?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2020-15050 published?
CVE-2020-15050 was published on 2020-07-13 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Supremainc Biostar 2

All CVEs affecting Supremainc Biostar 2 →

Other CWE-22 (Path Traversal) vulnerabilities

Browse all CWE-22 (Path Traversal) vulnerabilities →